Strategic time for tech and biotech
With the current volatility, now is the best time to look for stocks or exchange traded funds (ETFs) that are helping keep what’s left of the economy running, like technology and biotech.
Kris Walesby, ETF Securities chief executive, said internet providers, web conferencing, mobile, social media and online shopping stocks were the best examples.
“Netflix has had subscription spike in areas particularly hard hit by COVID-19, while Amazon has actually had to hire more people to manage their warehouses to cope with increased demand for delivery,” Walesby said.
“Netflix has also trialled a function to allow ‘Netflix parties’ which is an excellent opportunity to battle social isolation.
“Biotechnology companies globally are racing for the solution – it’s a bit of a lottery as to who will manage first – but worth noting the following: Moderna started clinical trials on a vaccine this week and Gilead’s anti-viral medications are looking promising as treatments.”
Biotech had previously been considered a volatile sector but was more valuable in the current environment.
“It’s fair to say in our increasingly global world, COVID-19 is not going to be the last time we have to take drastic measures to limit the spread of a pandemic virus and these companies have been positioned to step up quickly because of their ongoing work,” Walesby said.
Walesby shared a few other tips: “Generally agreed lessons from this period for investors include: 1. don’t sell quality assets in panic and at unreasonably low levels; 2. don’t try and pick the bottom; 3. consider slowly accumulating good assets at attractive prices and getting oneself positioned for the recovery, whenever it may come.”
AUTHOR
Chris Dastoor
Recommended for you
Fund managers may be operating in a squeezed environment, but a salary guide shows they are willing to pay up for specialist talent to diversify their fund range.
Reach Alternative Investments has entered into a strategic partnership with Russell Investments to bolster its wholesale private markets offering for financial advisers and investors.
Boutique investment consulting and research house Genium Investment Partners has announced a senior appointment to drive further growth in its research ratings business.
Nuveen has appointed a global head of estate, a successor to Chris McGibbon who steps down after almost 25 years.
